September 2017
Providence Cancer Center is currently conducting more than 150 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches. Please see the links below for studies in specific disease areas.
New trial studies targeted therapy for breast cancer
 
Patients with hormone-receptor-positive, HER2-positive metastatic breast cancer may qualify for a newly opened clinical trial at Providence Cancer Center . The PATINA trial expects to demonstrate that adding the targeted therapy palbociclib to standard therapies will prolong survival over standard therapies alone.

This trial is one of nearly 30 breast cancer studies currently open at Providence Cancer Center.
All current open studies:
New studies are posted frequently - please check our  website  for a complete list of our current studies. For more information, call 503-215-2614.